• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

TGRSRWRDVSRNFMRRYQSRVIQGLVAGETAQQIS details
Primary information
ID antitb_1982,
Name11120840
N-Terminal modificationGranulysin(36-70)
C-Terminal ModificationTGRSRWRDVSRNFMRRYQSRVIQGLVAGETAQQIS
Chemical ModificationFree
Linear/CyclicFree
Lengthbutanedione (BAD) or citraconic anhydride(CAH)
ChiralityLinear
Nature35
SourceL
OriginCationic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis
Cell Line25-40% Killing -25µM
Inhibition ConcentrationIn vitro
Sequence2000
CytotoxicityNA
In vivo ModelNA
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiescell wall
PMIDNA
Year of Publication Escherichia coli
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1983,
Name11120840
N-Terminal modificationGranulysin(36-70)
C-Terminal ModificationTGRSRWRDVSRNFMRRYQSRVIQGLVAGETAQQIS
Chemical ModificationFree
Linear/CyclicFree
Lengthbutanedione (BAD) or citraconic anhydride(CAH)
ChiralityLinear
Nature35
SourceL
OriginCationic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis
Cell Line45-60% Killing -100 µM
Inhibition ConcentrationIn vitro
Sequence2000
CytotoxicityNA
In vivo ModelNA
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiescell wall
PMIDNA
Year of Publication Escherichia coli
Tertiary Structure
(Technique)
Not Predicted),